AtriCure, Inc. Files 8-K on Financials
Ticker: ATRC · Form: 8-K · Filed: Jul 30, 2024 · CIK: 1323885
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: ATRC
TL;DR
ATRC filed an 8-K detailing financial results - check it out.
AI Summary
AtriCure, Inc. filed an 8-K on July 30, 2024, reporting on its financial condition and results of operations. The filing includes financial statements and exhibits related to the company's performance.
Why It Matters
This 8-K filing provides investors with crucial updates on AtriCure's financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- AtriCure, Inc. (company) — Registrant
- July 30, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Mason, OH (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 30, 2024.
What is the principal executive office address for AtriCure, Inc.?
The principal executive offices are located at 7555 Innovation Way, Mason, OH 45040.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for AtriCure, Inc.?
The Standard Industrial Classification (SIC) code for AtriCure, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 579 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2024-07-30 16:00:35
Filing Documents
- atrc-20240730.htm (8-K) — 28KB
- exhibit991-07302024.htm (EX-99.1) — 150KB
- image_0a.jpg (GRAPHIC) — 3KB
- 0001323885-24-000104.txt ( ) — 314KB
- atrc-20240730.xsd (EX-101.SCH) — 2KB
- atrc-20240730_lab.xml (EX-101.LAB) — 21KB
- atrc-20240730_pre.xml (EX-101.PRE) — 12KB
- atrc-20240730_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On July 30, 2024 , AtriCure, Inc. issued a press release regarding its financial results for the second quarter ended June 30, 2024. The Company will hold a conference call on July 30, 2024 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in Item 2.02 of Form 8-K and in the press release attached as Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in each of Item 2.02 of this Form 8-K and Exhibit 99.1 shall not be incorporated by reference in any filing or other document under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing or document.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits No. Description 99.1 Press Release dated July 30, 2024 relating to financial results for the second quarter ended June 30, 2024. 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATRICURE, INC. Dated: July 30, 2024 By: /s/ Angela L. Wirick Angela L. Wirick Chief Financial Officer